What is ATS's health score?

ATS Corp /ATS (ATS) has a TradeApes health score of 39 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is ATS's estimated fair value?

Based on our 5-year discounted cash flow model, ATS Corp /ATS's estimated fair value is $44.91 per share, representing a 62.8% upside from the current price. This is a model estimate, not a price target or investment recommendation.

Is ATS undervalued or overvalued?

Our model currently rates ATS as Undervalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

To Unlock Full Report

2 free score cards remaining

ATS Corp /ATS (ATS)

Technology Undervalued low weak

$27.58

Updated: 2026-07-18

TradeApes Score

Financial Strength

30 Weak

Operating Trend

40 Weak

Relative Value

40 Weak

Capital Allocation

45 Mixed

Risk Management

50 Mixed

Est. Fair Value $44.91

DCF Upside +62.8%

Sector Rank #10161 of 15019

Key Findings

+ Strong FCF growth — free cash flow up more than 20% year over year

Unlock Full Report →

− Sharp revenue decline — sales down more than 15% year over year

Unlock Full Report →

Industry Related Stocks

APPLIED OPTOELECTRONICS, INC. (AAOI) AAON, INC. (AAON) Apple Inc. (AAPL) Antiaging Quantum Living Inc. (AAQL) ABB LTD (ABBNY) ABB LTD (ABLZF)

See all Technology stocks →

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.